In vivo use of adenoviral vectors: effects on salivary gland structure.
Recently there has been considerable progress in the development of in vivo gene transfer technology. By this means, new genetic information may be introduced directly to cells, while the cells remain in their natural milieu. The ability to express exogenous proteins makes it possible to explore the functions of native or altered proteins and thereby develop new insights into cell function and dysfunction. We have demonstrated that the major salivary glands are efficiently infected by recombinant adenovirus vectors. These vectors are capable of expressing transgenes in both acinar and ductal cell types. Recently, we have developed vectors that contain cell-specific promoters so that proteins may be expressed in selected subpopulations of salivary cells. Early generations of adenoviral vectors elicited potent immune responses in vivo. However, modified vectors and adjunctive measures have improved the safety of gene transfer to salivary glands. Future studies will aim to increase the duration of adenovirus-based gene expression and to produce vector systems that are not toxic to the host.
O'Connell
B C
BC
Gene Transfer Unit, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892-1190, USA.
Redman
R S
RS
Zheng
C
C
D000256:Adenoviridae; D000818:Animals; D015967:Gene Expression Regulation, Viral; D018014:Gene Transfer Techniques; D008297:Male; D008854:Microscopy, Electron; D010306:Parotid Gland / Q000502:physiology* / Q000648:ultrastructure / Q000821:virology; D051381:Rats; D017208:Rats, Wistar; D013363:Submandibular Gland / Q000502:physiology* / Q000648:ultrastructure / Q000821:virology; D019076:Transgenes / Q000502:physiology